David R Nalin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David R Nalin

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Lancet (London, England)|August 29, 2018

50 years of oral rehydration therapy: the solution is still simpleDavid R Nalin, Richard A Cash

Pediatrics|April 3, 2002

CHOICE Study Group TrialNorbert Hirschhorn, David R Nalin, Richard A Cash

Vaccine|March 22, 2002

Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTAAlan Werzberger, Barbara Mensch, David R Nalin, et al.

Lancet (London, England)|July 31, 2002

Formulation of oral rehydration solutionNorbert Hirschhorn, David R Nalin, Richard A Cash, et al.

JAMA|June 3, 2004

Clinical concerns about reduced-osmolarity oral rehydration solutionDavid R Nalin, Norbert Hirschhorn, William Greenough, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Lancet (London, England)|August 29, 2018

50 years of oral rehydration therapy: the solution is still simpleDavid R Nalin, Richard A Cash

Pediatrics|April 3, 2002

CHOICE Study Group TrialNorbert Hirschhorn, David R Nalin, Richard A Cash

Vaccine|March 22, 2002

Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTAAlan Werzberger, Barbara Mensch, David R Nalin, et al.

Lancet (London, England)|July 31, 2002

Formulation of oral rehydration solutionNorbert Hirschhorn, David R Nalin, Richard A Cash, et al.

JAMA|June 3, 2004

Clinical concerns about reduced-osmolarity oral rehydration solutionDavid R Nalin, Norbert Hirschhorn, William Greenough, et al.

Pageof 2